Next-generation radiopharmaceuticals for oncology
Clarity Pharmaceuticals (claritypharmaceuticals.com) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 46th percentile of 18839 Healthcare brands.
Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company based in Eveleigh, Australia. It develops next-generation theranostic products-combining diagnostic imaging and targeted therapy-for oncology, using its proprietary SAR Technology platform optimized for copper isotopes. The company focuses on addressing manufacturing and logistical challenges in radiopharmaceuticals while targeting major and rare cancers such as prostate cancer, breast cancer, and neuroendocrine tumours. Its work is aimed at healthcare providers, researchers, and patients seeking advanced cancer diagnostic and therapeutic solutions.
| Brand Name | Clarity Pharmaceuticals |
|---|---|
| Domain | claritypharmaceuticals.com |
| Industry | Healthcare |
| Headquarters | Eveleigh, Australia |
| Main Competitors | Telix Pharmaceuticals (75/100), Novartis (Advanced Accelerator Applications) (75/100), Lantheus Holdings (80/100), POINT Biopharma (70/100), Fusion Pharmaceuticals (76/100), Curium Pharma (79/100) |
Moz Domain Authority 32/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #4,484,948 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, YouTube, Facebook, Instagram; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Clarity Pharmaceuticals?", Claude could identify the brand as of October 2026. Clarity Pharmaceuticals is an Australian clinical-stage radiopharmaceutical company developing targeted copper-based diagnostic and therapeutic products, most notably for prostate cancer using their SAR-bisPSMA technology with copper-64 and copper-67 isotopes. Best known for developing copper-based theranostic radiopharmaceuticals for prostate cancer imaging and treatment (SAR-bisPSMA).
When asked "Best brands similar to Clarity Pharmaceuticals?", Claude would recommend Clarity Pharmaceuticals as of October 2026. It's a notable name in the targeted radiopharmaceutical/theranostics space, especially relevant if discussing prostate cancer diagnostics or copper isotope-based therapies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Clarity Pharmaceuticals's main competitors in Healthcare: Telix Pharmaceuticals (75/100), Novartis (Advanced Accelerator Applications) (75/100), Lantheus Holdings (80/100), POINT Biopharma (70/100), Fusion Pharmaceuticals (76/100).
Sources: Brand Analyzer scan
Clarity Pharmaceuticals has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 19, trust 23, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Clarity Pharmaceuticals offers theranostic products-combining diagnostic imaging and targeted therapy-for oncology, built on its proprietary SAR Technology platform. This platform is designed for use with copper isotopes and targets major and rare cancers, including prostate cancer, breast cancer, and neuroendocrine tumours.
Clarity Pharmaceuticals scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company headquartered in Eveleigh, Australia. It develops next-generation theranostic products that combine diagnostic imaging and targeted radiotherapy for the treatment of cancer.
Clarity Pharmaceuticals develops radiopharmaceutical products for oncology, using its proprietary SAR Technology platform. This platform is designed for use with copper isotopes, enabling targeted imaging and therapeutic applications while addressing manufacturing and logistical limitations common in the radiopharmaceutical industry.
Clarity Pharmaceuticals can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Clarity Pharmaceuticals' products and research are intended for oncology patients, healthcare providers, and the medical research community seeking advanced diagnostic and therapeutic radiopharmaceutical solutions, particularly for prostate cancer, breast cancer, and neuroendocrine tumours.
Clarity Pharmaceuticals is known for its SAR Technology platform, a proprietary system optimized for use with copper isotopes in radiopharmaceutical imaging and therapy. The company applies this technology to develop theranostic products for cancers including prostate cancer, breast cancer, and neuroendocrine tumours.
Clarity Pharmaceuticals scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Clarity Pharmaceuticals has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (19/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #4,484,948 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 32/100 and thin schema.org structured data. In a live check, Claude could already identify Clarity Pharmaceuticals from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Clarity Pharmaceuticals: Claire House Children's Hospice (75/100), CKO Kickboxing (75/100), Clearfork Academy (75/100), Cleveland Clinic Abu Dhabi (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.